Skip to main content
Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease.

The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.

Publisher: Spandidos Publications

More about this publication?
Volume 2, Number 4, 2011

Articles

The emerging role of CXCL10 in cancer (Review)
pp. 583-589(7)
Authors: Liu; Guo; Stiles

Favourites:
ADD

The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review)
pp. 591-597(7)
Authors: Shigetomi, Hiroshi; Oonogi, Akira; Tsunemi, Taihei; Tanase, Yasuhito; Yamada, Yoshihiko; Kajihara, Hirotaka; Yoshizawa, Yoriko; Furukawa, Naoto; Haruta, Shoji; Yoshida, Shozo; Sado, Toshiyuki; Oi, Hidekazu; Kobayashi, Hiroshi

Favourites:
ADD

Protease-activated receptors in cancer: A systematic review
pp. 599-608(10)
Authors: Han, Na; Jin, Ketao; He, Kuifeng; Cao, Jiang; Teng, Lisong

Favourites:
ADD
Favourites:
ADD

MicroRNA profiling of gastric cancer patients from formalinfixed paraffinembedded samples
pp. 613-619(7)
Authors: Osawa; Shimada; Sekine; Okumura; Nagata; Fukuoka; Tsukada

Favourites:
ADD
Favourites:
ADD

Establishment of primary mouse lung adenocarcinoma cell culture
pp. 629-632(4)
Authors: Luo, Shuli; Sun, Mei; Jiang, Rui; Wang, Guan; Zhang, Xinyi

Favourites:
ADD

Retroperitoneal primary mucinous adenocarcinoma: A case report
pp. 633-636(4)
Authors: Jiang; Jin; You; Fang; Xu

Favourites:
ADD
Favourites:
ADD

Extranodal follicular dendritic cell sarcoma in mesentery: A case report
pp. 649-652(4)
Authors: Li; Jin; Yu; Teng; Zhou; Wang; Teng; Cao

Favourites:
ADD
Favourites:
ADD

CD38 expression as response of hematopoietic system to cancer
pp. 659-664(6)
Authors: Albeniz; Demir-Coşkun; Türker-Şener; Baş; Asoğlu; Nurten

Favourites:
ADD

Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways
pp. 665-668(4)
Authors: Heinze; Chan; Mory; Khavari; Alavi; Chung; Nishimura; Weisbart

Favourites:
ADD
Favourites:
ADD

Surgical resection using retroperitoneal approach for solitary fibrous tumor in the pelvis
pp. 675-677(3)
Authors: Shoji; Nakano; Yamamoto; Okada; Nagata; Sekido; Terayama; Ito; Uchida

Favourites:
ADD

Three-gene signature predicts disease progression of non-muscle invasive bladder cancer
pp. 679-684(6)
Authors: Jeong, Pildu; Ha, Yun-Sok; Cho, In-Chang; Yun, Seok-Joong; Yoo, Eun Sang; Kim, Isaac Yi; Choi, Yung Hyun; Moon, Sung-Kwon; Kim, Wun-Jae

Favourites:
ADD
Favourites:
ADD

Prevalence of human papillomavirus in university young women
pp. 701-706(6)
Authors: Montalvo; Lobato; Villanueva; Borquez; Navarrette; Abarca; Calaf

Favourites:
ADD
Favourites:
ADD

EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages
pp. 719-724(6)
Authors: Mohammed; Rodriguez; Garcia; Garcia; Dominguez; Peña; Herrera; Gomez; Diaz; Soldevilla; Herrera; Silva; Bonilla

Favourites:
ADD

Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma
pp. 725-729(5)
Authors: He, Qian; Wei, Jiazhang; Zhang, Jinyan; Jiang, Heng; Wang, Shumin; Zhou, Xiaoying; Zhang, Zhe; Huang, Guangwu; Watanabe, Hiroshi; Su, Jiping

Favourites:
ADD

Survival of untreated advanced colorectal cancer patients
pp. 731-733(3)
Author: Stathopoulos

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells
pp. 753-758(6)
Authors: Jiang; Yu; Du; Ni; Han; Gao; Li; Wu; Zheng; Tan

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content